These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9839152)

  • 41. Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China.
    Zhang L; Zou X; Zhang D; Li X; Zhao P; Ling L
    PLoS One; 2015; 10(10):e0139942. PubMed ID: 26484772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A follow-up study of dropouts from a methadone maintenance program.
    Boudouris J
    Int J Addict; 1976; 11(5):807-30. PubMed ID: 1017909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alcohol use in combination with cocaine, heroin and methadone by medical examiner cases.
    Haberman PW; Noble JA; Dufour MC
    J Stud Alcohol; 1995 May; 56(3):344-7. PubMed ID: 7623474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.
    Hickman M; Carnwath Z; Madden P; Farrell M; Rooney C; Ashcroft R; Judd A; Stimson G
    J Urban Health; 2003 Jun; 80(2):274-87. PubMed ID: 12791803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mortality of drug users attending public treatment centers in Italy 1998-2001: a cohort study].
    Ferri M; Bargagli AM; Faggiano F; Belleudi V; Salamina G; Vigna-Taglianti F; Davoli M; Perucci CA;
    Epidemiol Prev; 2007; 31(5):276-82. PubMed ID: 18274231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonfatal overdose among heroin users in southwestern China.
    Yin L; Qin G; Ruan Y; Qian HZ; Hao C; Xie L; Chen K; Zhang Y; Xia Y; Wu J; Lai S; Shao Y
    Am J Drug Alcohol Abuse; 2007; 33(4):505-16. PubMed ID: 17668336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Premature discharge from methadone treatment: patient perspectives.
    Reisinger HS; Schwartz RP; Mitchell SG; Peterson JA; Kelly SM; O'Grady KE; Marrari EA; Brown BS; Agar MH
    J Psychoactive Drugs; 2009 Sep; 41(3):285-96. PubMed ID: 19999682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality Risk Among Heroin Abusers: Clients and Non-clients of Public Treatment Centers for Drug Addiction.
    Pavarin RM
    Subst Use Misuse; 2015; 50(13):1690-6. PubMed ID: 26595386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heroin dependence in an English town: 33-year follow-up.
    Rathod NH; Addenbrooke WM; Rosenbach AF
    Br J Psychiatry; 2005 Nov; 187():421-5. PubMed ID: 16260816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overdose deaths attributed to methadone and heroin in New York City, 1990-1998.
    Bryant WK; Galea S; Tracy M; Markham Piper T; Tardiff KJ; Vlahov D
    Addiction; 2004 Jul; 99(7):846-54. PubMed ID: 15200580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlates of methadone patients' lengths of stay for first and second admissions.
    Steer RA; Kotzker E
    Drug Alcohol Depend; 1978 Nov; 3(6):399-403. PubMed ID: 720210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
    Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies for preventing heroin overdose.
    Sporer KA
    BMJ; 2003 Feb; 326(7386):442-4. PubMed ID: 12595388
    [No Abstract]   [Full Text] [Related]  

  • 54. Patterns of attendance in methadone maintenance treatment program in Yunnan Province, China.
    Che Y; Assanangkornchai S; McNeil E; Li J; You J; Chongsuvivatwong V
    Am J Drug Alcohol Abuse; 2011 May; 37(3):148-54. PubMed ID: 21413914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methadone evaluation: some additional thoughts.
    Jacobs PE; Doft EB; Karras A; Koger J
    Int J Addict; 1979 Feb; 14(2):207-13. PubMed ID: 447430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan].
    Zhou Y; Luo W; Cao XB; Zhang B; Wu ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):648-52. PubMed ID: 27188355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment.
    Mégarbane B; Buisine A; Jacobs F; Résière D; Chevillard L; Vicaut E; Baud FJ
    J Subst Abuse Treat; 2010 Jun; 38(4):403-7. PubMed ID: 20189341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
    Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
    Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
    Buckley V; Razaghi A; Haber P
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatal methadone and heroin overdoses: time trends in England and Wales.
    Neeleman J; Farrell M
    J Epidemiol Community Health; 1997 Aug; 51(4):435-7. PubMed ID: 9328553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.